About Keith Rosmarin
Keith Rosmarin is president and chief financial officer at Salus Scientific, a medical technology company that aims to protect clinicians in fluoroscopy suites. He guides the company's finances and strategy. He has about twenty years of experience in finance and investment management. In 2020 he became the first investor in Salus who was not a founder, backing it before it had a product to sell. He then designed the company's structure, capital setup and financing strategy. He has since led the main financing rounds and the commercial launch of the GLiFT™ platform.
Rosmarin founded Harbor Hill Investments, a private equity fund, and first invested in Salus through it. He stays active across the fund's portfolio. He sits on the board of LnQ Inc. and advises the leaders of portfolio companies. Earlier he worked at Surveyor Capital, part of Citadel LLC, as director of US Fundamental Trading. Before that, he spent more than 15 years in two roles. He was a director in Citigroup's equity division and a partner at Level Global Investors, LP. He earned a dual degree in economics and government at Lafayette College.
Experience
This experience comes from official bios and from SEC filings. For roles taken from filings, the years are when the filings name Keith Rosmarin in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Keith Rosmarin works with at each company, as listed on that company's latest Form D.
